"Neighborhood Donor Center location that collects blood products from donors to supply partner hospitals for those in need."

During the past decade, Hoxworth Blood Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hoxworth Blood Center" #1 sponsor was "Terumo BCT" with 7 trials, followed by "Cerus Corporation" with 3 trials sponsored, "Haemonetics Corporation" with 2 trials sponsored, "Hemanext" with 2 trials sponsored and "U.S. Army Medical Research and Development Command" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hoxworth Blood Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Cerus Corporation" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "U.S. Army Medical Research and Development Command" with 1 trials as a collaborator and "United States Army Medical Materiel Development Activity" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hoxworth Blood Center" are "Healthy Volunteers" (4 trials), "Healthy" (3 trials), "Thrombocytopenia" (2 trials), "Anemia" (1 trials) and "Anticoagulant Reversal" (1 trials). Many other conditions were trialed in "Hoxworth Blood Center" in a lesser frequency.

Most popular intervention types in "Hoxworth Blood Center" are "Device" (13 trials), "Biological" (9 trials), "Drug" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fresh Frozen Plasma (FFP)" (2 trials), "Trima Accel System with Version 7.0 Software" (2 trials), "A-ECO" (1 trials), "AS-3 (Control)" (1 trials) and "Autologous Freeze Dried Plasma (FDP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hoxworth Blood Center" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Hoxworth Blood Center". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hoxworth Blood Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hoxworth Blood Center, 8 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".